THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS
Aim. To evaluate, under the frame of prospective registry, the 12-month outcomes and risks in patients with arterial hypertension (AH), ischemic heart disease (CHD), chronic heart failure (CHF) and atrial fibrillation (AF) in the real outpatient practice in Ryazan Region. Material and methods. Into...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2015-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/119 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849408542742675456 |
|---|---|
| author | S. A. Boytsov М. М. Lukyanov S. S. Yakushin S. Yu. Martsevich A. N. Vorobyev A. V. Zagrebelny K. G. Pereverzeva Е. А. Pravkina A. D. Deev E. Yu. Andreenko A. I. Ershova A. N. Meshkov R. P. Myasnikov S. S. Serdyuk M. S. Kharlap E. V. Bazaeva A. N. Kozminsky K. A. Moseychuk V. G. Klyashtorny E. V. Kudryashov |
| author_facet | S. A. Boytsov М. М. Lukyanov S. S. Yakushin S. Yu. Martsevich A. N. Vorobyev A. V. Zagrebelny K. G. Pereverzeva Е. А. Pravkina A. D. Deev E. Yu. Andreenko A. I. Ershova A. N. Meshkov R. P. Myasnikov S. S. Serdyuk M. S. Kharlap E. V. Bazaeva A. N. Kozminsky K. A. Moseychuk V. G. Klyashtorny E. V. Kudryashov |
| author_sort | S. A. Boytsov |
| collection | DOAJ |
| description | Aim. To evaluate, under the frame of prospective registry, the 12-month outcomes and risks in patients with arterial hypertension (AH), ischemic heart disease (CHD), chronic heart failure (CHF) and atrial fibrillation (AF) in the real outpatient practice in Ryazan Region. Material and methods. Into the outpatient registry RECVASA (REgistry of CardioVAScular diseases) totally 3690 patients included with AH, CHD, CHF, AF and their comorbidity, visited 3 outpatient institutions in Ryzan city: 1047 (28%) of men and 2643 women, mean age 66,1±12,9 y.o. The estimation of 12-mint risk of events fter inclusion in registry RECVASA was done for 3619 (98,1%) participants. Results. By 12 month after inclusion 168 patients (4,6%) died, had stroke (S) — 62 (1,7%), myocardial infarction (MI) — 26 (0,7%), cardiovascular surgery (CVS) — 6 (0,2%). Totally 235 hospitalizations for CVD registered. The risk of death, MI development and S had been increasing by 5-9% every year of patient age, and CVD hospitalization — decreased by 2%. Combined death risk and cardiovascular death risk were significantly higher (1,3-6,4 times) with anamnesis of MI, S, diabetes mellitus (DM), chronic obstructive lung disease (COPD), CHF of 3-4 functional class (FC), in males and with blood pressure (BP) <110/75 mmHg, heart rate (HR) >90 bpm, glomerular filtration rate (GFR) <45 ml/min. Higher MI risk (1,8-3,4 times) was linked to the anamnesis of diabetes and MI, angina pectoris (FC 3-4) and GFR <45 ml/min. MI risk was higher by 2,4-7,2 times in patients with anamnesis of MI, permanent AF, and with combinations of AH, CHD, CHF and AF, with BP <110/75 mmHg and >180/110 mmHg, HR >90/min. Risk of all-cause death was lower in those who received p-adrenoblockers, angiotensin-converting enzyme inhibitors (iACE) and angiotensin receptor blockers (ARB) 1,4-1,5 times, death from cardiovascular causes — with iACE and ARB — 2 times lower. Patients on p-blockers had 1,8 times lower risk of MI. Conclusion. Prospective follow-up of cardiovascular patients under the frame of RECVASA registry showed significant negative influence on prognosis the following: age, male gender, anamnesis of MI and S, DM, COPD, CHF (3-4 FC), angina (3-4 FC), permanent AF, BP <110/75 and >180/110 mmHg, GFR <45 ml/min, HR >90/min, combination of AH, CHD, CHF and AH, CHD, CHF, AF. Positive influence on prognosis with CVD had treatment with p-adrenoblockers, iACE, ARB. |
| format | Article |
| id | doaj-art-39bf6cc48a474ce989494a63d24c741e |
| institution | Kabale University |
| issn | 1728-8800 2619-0125 |
| language | Russian |
| publishDate | 2015-02-01 |
| publisher | «SILICEA-POLIGRAF» LLC |
| record_format | Article |
| series | Кардиоваскулярная терапия и профилактика |
| spelling | doaj-art-39bf6cc48a474ce989494a63d24c741e2025-08-20T03:35:45Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252015-02-01141536210.15829/1728-8800-2015-1-53-62119THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTSS. A. Boytsov0М. М. Lukyanov1S. S. Yakushin2S. Yu. Martsevich3A. N. Vorobyev4A. V. Zagrebelny5K. G. Pereverzeva6Е. А. Pravkina7A. D. Deev8E. Yu. Andreenko9A. I. Ershova10A. N. Meshkov11R. P. Myasnikov12S. S. Serdyuk13M. S. Kharlap14E. V. Bazaeva15A. N. Kozminsky16K. A. Moseychuk17V. G. Klyashtorny18E. V. Kudryashov19State Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowRyazan State Medical University n.a. I. P. Pavlov. Ryazan, RussiaState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowRyazan State Medical University n.a. I. P. Pavlov. Ryazan, RussiaState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowRyazan State Medical University n.a. I. P. Pavlov. Ryazan, RussiaRyazan State Medical University n.a. I. P. Pavlov. Ryazan, RussiaState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowRyazan State Medical University n.a. I. P. Pavlov. Ryazan, RussiaRyazan State Medical University n.a. I. P. Pavlov. Ryazan, RussiaState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowState Scientific-Research Center of Preventive Medicine of the Ministry of Healthcare. MoscowAim. To evaluate, under the frame of prospective registry, the 12-month outcomes and risks in patients with arterial hypertension (AH), ischemic heart disease (CHD), chronic heart failure (CHF) and atrial fibrillation (AF) in the real outpatient practice in Ryazan Region. Material and methods. Into the outpatient registry RECVASA (REgistry of CardioVAScular diseases) totally 3690 patients included with AH, CHD, CHF, AF and their comorbidity, visited 3 outpatient institutions in Ryzan city: 1047 (28%) of men and 2643 women, mean age 66,1±12,9 y.o. The estimation of 12-mint risk of events fter inclusion in registry RECVASA was done for 3619 (98,1%) participants. Results. By 12 month after inclusion 168 patients (4,6%) died, had stroke (S) — 62 (1,7%), myocardial infarction (MI) — 26 (0,7%), cardiovascular surgery (CVS) — 6 (0,2%). Totally 235 hospitalizations for CVD registered. The risk of death, MI development and S had been increasing by 5-9% every year of patient age, and CVD hospitalization — decreased by 2%. Combined death risk and cardiovascular death risk were significantly higher (1,3-6,4 times) with anamnesis of MI, S, diabetes mellitus (DM), chronic obstructive lung disease (COPD), CHF of 3-4 functional class (FC), in males and with blood pressure (BP) <110/75 mmHg, heart rate (HR) >90 bpm, glomerular filtration rate (GFR) <45 ml/min. Higher MI risk (1,8-3,4 times) was linked to the anamnesis of diabetes and MI, angina pectoris (FC 3-4) and GFR <45 ml/min. MI risk was higher by 2,4-7,2 times in patients with anamnesis of MI, permanent AF, and with combinations of AH, CHD, CHF and AF, with BP <110/75 mmHg and >180/110 mmHg, HR >90/min. Risk of all-cause death was lower in those who received p-adrenoblockers, angiotensin-converting enzyme inhibitors (iACE) and angiotensin receptor blockers (ARB) 1,4-1,5 times, death from cardiovascular causes — with iACE and ARB — 2 times lower. Patients on p-blockers had 1,8 times lower risk of MI. Conclusion. Prospective follow-up of cardiovascular patients under the frame of RECVASA registry showed significant negative influence on prognosis the following: age, male gender, anamnesis of MI and S, DM, COPD, CHF (3-4 FC), angina (3-4 FC), permanent AF, BP <110/75 and >180/110 mmHg, GFR <45 ml/min, HR >90/min, combination of AH, CHD, CHF and AH, CHD, CHF, AF. Positive influence on prognosis with CVD had treatment with p-adrenoblockers, iACE, ARB.https://cardiovascular.elpub.ru/jour/article/view/119registrycardiovascular diseasesprospective follow-upprisk factorsoutcomesoutpatient practicecombined cardiovascular pathologycomorbidity |
| spellingShingle | S. A. Boytsov М. М. Lukyanov S. S. Yakushin S. Yu. Martsevich A. N. Vorobyev A. V. Zagrebelny K. G. Pereverzeva Е. А. Pravkina A. D. Deev E. Yu. Andreenko A. I. Ershova A. N. Meshkov R. P. Myasnikov S. S. Serdyuk M. S. Kharlap E. V. Bazaeva A. N. Kozminsky K. A. Moseychuk V. G. Klyashtorny E. V. Kudryashov THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS Кардиоваскулярная терапия и профилактика registry cardiovascular diseases prospective follow-upp risk factors outcomes outpatient practice combined cardiovascular pathology comorbidity |
| title | THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS |
| title_full | THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS |
| title_fullStr | THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS |
| title_full_unstemmed | THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS |
| title_short | THE OUTPATIENT BASED REGISTRY RECVASA: PROSPECTIVE FOLLOW-UP DATA, RISK EVLUATION AND OUTCOMES IN CARDIOVASCULAR PATIENTS |
| title_sort | outpatient based registry recvasa prospective follow up data risk evluation and outcomes in cardiovascular patients |
| topic | registry cardiovascular diseases prospective follow-upp risk factors outcomes outpatient practice combined cardiovascular pathology comorbidity |
| url | https://cardiovascular.elpub.ru/jour/article/view/119 |
| work_keys_str_mv | AT saboytsov theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT mmlukyanov theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT ssyakushin theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT syumartsevich theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT anvorobyev theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT avzagrebelny theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT kgpereverzeva theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT eapravkina theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT addeev theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT eyuandreenko theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT aiershova theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT anmeshkov theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT rpmyasnikov theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT ssserdyuk theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT mskharlap theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT evbazaeva theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT ankozminsky theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT kamoseychuk theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT vgklyashtorny theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT evkudryashov theoutpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT saboytsov outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT mmlukyanov outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT ssyakushin outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT syumartsevich outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT anvorobyev outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT avzagrebelny outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT kgpereverzeva outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT eapravkina outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT addeev outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT eyuandreenko outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT aiershova outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT anmeshkov outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT rpmyasnikov outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT ssserdyuk outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT mskharlap outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT evbazaeva outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT ankozminsky outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT kamoseychuk outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT vgklyashtorny outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients AT evkudryashov outpatientbasedregistryrecvasaprospectivefollowupdatariskevluationandoutcomesincardiovascularpatients |